Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

August 06, 2012

Pfizer Inc. v. Teva Pharmaceuticals USA

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. February 06, 2014

    Fed. Circ. OKs Ruling Barring Generic Lyrica Until 2018

    Pfizer Inc. on Thursday won a ruling from the Federal Circuit upholding a lower court's decision blocking a slew of generic-drug makers, including Teva Pharmaceuticals USA Inc. and Actavis Inc., from selling generic versions of its popular nerve pain drug Lyrica until the patent for the drug expires in 2018.

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login